Professur für Zelluläre und Molekulare Neurophysiologie

The elegance of prickly sensations (2022) Imambocus BN, Soba P Journal article Short Report of Longitudinal CGRP-Measurements in Migraineurs During a Hypoxic Challenge (2022) Frank F, Kaltseis K, Meßlinger K, Broessner G Journal article The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow (2022) Dux M, Vogler B, Kuhn A, Mackenzie KD, Stratton J, Meßlinger K Journal article Cyclic changes of sensory parameters in migraine patients (2022) Helfenstein C, Strupf M, Stefke A, Fraunberger B, Renner B, Suchantke I, Rothermel M, et al. Journal article Petasites for Migraine Prevention: New Data on Mode of Action, Pharmacology and Safety. A Narrative Review (2022) Borlak J, Diener HC, Kleeberg-Hartmann J, Meßlinger K, Silberstein S Journal article, Review article Transient activation of spinal trigeminal neurons in a rat model of hypoxia-induced headache (2021) Waldmann D, Meßlinger K Journal article Fremanezumab, an anti-CGRP monoclonal antibody, reduces stimulated CGRP release from rat cranial dura mater (2019) Vogler B, Nakajima J, Mackenzie K, Stratton J, Meßlinger K Conference contribution CGRP outflow from the meninges into blood and cerebrospinal fluid (2019) Dux MJ, Risch M, Sertel-Nakajima J, Meßlinger K Conference contribution Cardio- and cerebrovascular safety of erenumab, a monoclonal antibody targeting CGRP receptors – important studies on human isolated arteries (2019) Meßlinger K, Maassen van den Brink A Journal article Why is the therapeutic effect of acute antimigraine drugs delayed? A review of controlled trials and hypotheses about the delay of effect (2019) Tfelt-Hansen P, Meßlinger K Journal article, Review article